Inventor
Nathan B. Mantlo
Inventor
Brownsburg, IN, US
Overview
Patents· 52 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds46%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
A61KPreparations for medical, dental or toiletry purposes4%
C07CAcyclic or carbocyclic compounds2%
C07HSugars1%
PatentTitleYear
8,697,849'Pyrazole compounds'20148,106,077'Compounds and methods for modulating FXR'20127,786,108'Compounds and method for treating dyslipidemia'20107,749,992'Compounds and methods for treating dislipidemia'20107,655,641'Sulfonamide derivatives as PPAR modulators'20107,598,266'Fused heterocyclic derivatives as PPAR modulators'20097,544,812'Peroxisome proliferator activated receptor agonists'20097,544,707'Bicyclic derivatives as PPAR modulators'20097,528,160'Fused heterocyclic derivatives as PPAR modulators'20097,507,832'Triazole PPAR modulators'20097,504,433'Thiophene derivative PPAR modulators'20097,470,705'Compounds and methods for treating dyslipidemia'20087,396,850'Pyrazole derivative as PPAR modulator'20087,384,965'Fused heterocyclic derivatives as PPAR modulators'20087,304,062'Peroxisome proliferator activated receptor alpha agonists'20077,259,175'Peroxisome proliferator activated receptor modulators'20077,205,321'Peroxisome proliferator activated receptor alpha agonists'20077,176,224'Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists'20077,153,878'Peroxisome proliferator activated receptor modulators'20066,649,604'Substituted pyridone compounds and methods of use'20036,610,698'Substituted pyrimidine compounds and methods of use'20036,605,634'Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents'20036,458,813'Substituted pyridine compounds and methods of use'20026,440,973'Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents'20026,420,385'Substituted pyrimidinone and pyridone compounds and methods of use'20026,410,729'Substituted pyrimidine compounds and methods of use'20026,333,341'Substituted pyridine compounds and methods of use'20016,184,237'Substituted pyridine compounds and methods of use'20016,180,643'Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents'20016,174,901'Substituted pyridine and pyridazine compounds and methods of use'20016,096,753'Substituted pyrimidinone and pyridone compounds and methods of use'20006,022,884'Substituted pyridine compounds and methods of use'20005,837,719'2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use'19985,792,778'2-substituted aryl pyrroles, compositions containing such compounds and methods of use'19985,776,954'Substituted pyridyl pyrroles, compositions containing such compounds and methods of use'19985,554,625'Substituted biphenylmethylimidazopyridines'19965,441,959'Substituted quinazolinones bearing acidic functional groups as angiotensin II antagonists'19955,412,097'Heterocyclic compounds bearing acidic functional groups as angiotensin II antagonists'19955,389,660'Substituted imidazo-fused 5-membered ring heterocycles as angiotensin II antagonists'19955,332,744'Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists'19945,281,614'Substituted 1,2,4-triazoles bearing acidic functional groups as angiotensin II antagonists'19945,238,942'Substituted quinazolinones bearing acidic functional groups as angiotensin II antagonists'19935,223,501'Substituted pyrimidinones bearing acidic functional groups as angiotensin II antagonists'19935,223,499'6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists'19935,164,407'Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin II antagonsists'19925,162,340'Substituted 1-(2H)-isoquinolinones bearing acidic functional groups as angiotensin II antagonists'19925,162,325'Angiotensin II antagonists incorporating a substituted benzyl element'19925,157,026'Oxo-purines as angiotensin II antagonists'19925,128,327'Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle'19925,124,335'Substituted pyrollo-fused 6 membered heterocycles as angiotensin II antagonists'19925,102,880'Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists'19925,064,825'Angiotensin II antagonists'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–1998Patents assigned to MERCK & CO INC (20)· patent assignee history
1991–1996Based in Westfield, NJ, US· patent location history
1995Based in Ledyard, CT, US· patent location history
1998–2003Based in Lafayette, CO, US· patent location history
2000–2003Patents assigned to AMGEN INC (13)· patent assignee history
2006–2014Patents assigned to LILLY CO ELI (19)· patent assignee history
2006–2014Based in Brownsburg, IN, US· patent location history
2012Patents assigned to BELL MICHAEL GREGORY (1)· patent assignee history
2012Patents assigned to DOTI ROBERT ANTHONY (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK & CO INC | 20 | 1991–1998 |
| LILLY CO ELI | 19 | 2006–2014 |
| AMGEN INC | 13 | 2000–2003 |
| BELL MICHAEL GREGORY | 1 | 2012 |
| DOTI ROBERT ANTHONY | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Brownsburg, IN, US | 19 | 2006–2014 |
| Lafayette, CO, US | 16 | 1998–2003 |
| Westfield, New Jersey, US | 16 | 1991–1996 |
| Ledyard, CT, US | 1 | 1995 |